首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:American health and drug benefits

缩写:

ISSN:1942-2962

e-ISSN:1942-2970

IF/分区:1.5/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引673
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Drew A Helmer,Nilanjana Dwibedi,Mazhgan Rowneki et al. Drew A Helmer et al.
Background: Veterans with diabetes and mental health conditions have a higher risk for suboptimal care and complications related to their diseases than veterans with diabetes who do not have mental health conditions. We h...
In response to the COVID-19 pandemic, in April 2020 the Association for Value-Based Cancer Care (AVBCC) introduced a series of webcasts titled "COVID-19 Impact on the Cancer Care Delivery Ecosystem." The following articles highlight some of...
Madison M Wempe,Mark D Stewart,Daniel Glass et al. Madison M Wempe et al.
Background: Diagnostic tests, including US Food and Drug Administration (FDA)-approved tests and laboratory-developed tests, are frequently used to guide care for patients with cancer, and, recently, have been the subject...
Suela Sulo,David Lanctin,Josh Feldstein et al. Suela Sulo et al.
Background: Hospital-based, nutrition-focused interventions have significantly lowered the cost-associated burden of poor nutrition through a reduction in healthcare resource utilization (HCRU). However, for patients at r...
Qingqing Xu,Sarah S Laxa,Omar Serna et al. Qingqing Xu et al.
Background: Several medications, including long-acting bronchodilators (LABDs), are critical to the management of chronic obstructive pulmonary disease (COPD). Clinical guidelines recommend the initiation of an LABD for C...
Allison Petrilla,Elizabeth Marrett,Xian Shen et al. Allison Petrilla et al.
Background: Significant public health concerns exist regarding the misuse and abuse of prescription opioids. Abuse-deterrent formulation (ADF) opioids may be leveraged as an important tool for combating the current opioid...